(ALRIB) Riber S.A - Overview
Sector: Technology | Industry: Semiconductor Equipment & Materials | Exchange: PA (France) | Market Cap: 271m EUR | Total Return: 558.8% in 12m
Total Rating 47
Safety 71
Buy Signal 1.65
Semiconductor Equipment & Materials
Industry Rotation: -9.4
Industry Rotation: -9.4
Market Cap:
315M
Avg Turnover: 4.50M
Avg Turnover: 4.50M
Risk 3d forecast
Volatility130%
VaR 5th Pctl16.8%
VaR vs Median-30.6%
Reward TTM
Sharpe Ratio2.59
Rel. Str. IBD99.6
Rel. Str. Peer Group95.9
Character TTM
Beta1.864
Beta Downside0.667
Hurst Exponent0.641
Drawdowns 3y
Max DD40.26%
CAGR/Max DD2.86
CAGR/Mean DD8.81
Warnings
Interest Coverage Ratio -88.8 is critical
Tailwinds
Leader, Tailwind, Avwap Ph Month
Description: ALRIB Riber S.A
Riber S.A. provides molecular beam epitaxy (MBE) products and related services for the compound semiconductor in France. The company offers MBE systems, such as research and pilot production systems, real-time curvature measurement products, and laser passivation tools; and MBE sources, including effusion cells, gas and valved sources, resistive cells, and valved cracker sources, as well as MBE heaters and manipulators. It also provides MBE accessories and services, OEM components and systems, and software products. The company serves power and RF electronics, lasers, IR detectors, displays, passivation, materials, solar, and OEM markets. Riber S.A. was founded in 1964 and is based in Bezons, France.
Headlines to Watch Out For
Piotroski VR‑10 (Strict)
6.5
| Net Income: 9.32m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 8.70 > 1.0 |
| NWC/Revenue: 19.96% < 20% (prev 25.80%; Δ -5.83% < -1%) |
| CFO/TA 0.17 > 3% & CFO 9.48m > Net Income 9.32m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.3m) vs 12m ago 1.07% < -2% |
| Gross Margin: 37.06% > 18% (prev 0.37%; Δ 3.67k% > 0.5%) |
| Asset Turnover: 154.8% > 50% (prev 116.1%; Δ 38.66% > 0%) |
| Interest Coverage Ratio: -88.82 > 6 (EBITDA TTM -1.73m / Interest Expense TTM 51.0k) |
Altman Z''
2.36
| A: 0.29 (Total Current Assets 43.6m - Total Current Liabilities 27.4m) / Total Assets 55.4m |
| B: 0.09 (Retained Earnings 5.24m / Total Assets 55.4m) |
| C: -0.09 (EBIT TTM -4.53m / Avg Total Assets 52.6m) |
| D: 0.67 (Book Value of Equity 18.8m / Total Liabilities 28.1m) |
| Altman-Z'' = 2.36 = BBB |
Beneish M
-2.22
| DSRI: 1.71 (Receivables 18.0m/7.44m, Revenue 81.5m/57.9m) |
| GMI: 0.99 (GM 37.06% / 36.85%) |
| AQI: 0.90 (AQ_t 0.13 / AQ_t-1 0.15) |
| SGI: 1.41 (Revenue 81.5m / 57.9m) |
| TATA: -0.00 (NI 9.32m - CFO 9.48m) / TA 55.4m) |
| Beneish M = -2.22 (Cap -4..+1) = BB |
What is the price of ALRIB shares?
As of May 23, 2026, the stock is trading at EUR 15.36 with a total of 584,861 shares traded.
Over the past week, the price has changed by +18.70%, over one month by +18.15%, over three months by +166.20% and over the past year by +558.80%.
Over the past week, the price has changed by +18.70%, over one month by +18.15%, over three months by +166.20% and over the past year by +558.80%.
Is ALRIB a buy, sell or hold?
Riber S.A has no consensus analysts rating.
What are the forecasts/targets for the ALRIB price?
| Analysts Target Price | - | - |
Riber S.A (ALRIB) - Fundamental Data Overview
as of 23 May 2026
Market Cap USD = 315.1m (271.1m EUR * 1.1625 EUR.USD)P/E Trailing = 51.6
P/E Forward = 25.3165
P/S = 6.7255
P/B = 9.7911
P/EG = 10.9615
Revenue TTM = 81.5m EUR
EBIT TTM = -4.53m EUR
EBITDA TTM = -1.73m EUR
Long Term Debt = 94.0k EUR (from longTermDebt, last quarter)
Short Term Debt = 1.48m EUR (from shortTermDebt, last quarter)
Debt = 2.09m EUR (from shortLongTermDebtTotal, last quarter) + Leases 350k
Net Debt = -5.39m EUR (calculated: Debt 2.09m - CCE 7.47m)
Enterprise Value = 265.7m EUR (271.1m + Debt 2.09m - CCE 7.47m)
Interest Coverage Ratio = -88.82 (Ebit TTM -4.53m / Interest Expense TTM 51.0k)
EV/FCF = 36.41x (Enterprise Value 265.7m / FCF TTM 7.30m)
FCF Yield = 2.75% (FCF TTM 7.30m / Enterprise Value 265.7m)
FCF Margin = 8.96% (FCF TTM 7.30m / Revenue TTM 81.5m)
Net Margin = 11.45% (Net Income TTM 9.32m / Revenue TTM 81.5m)
Gross Margin = 37.06% ((Revenue TTM 81.5m - Cost of Revenue TTM 51.3m) / Revenue TTM)
Gross Margin QoQ = 39.63% (prev 36.15%)
Tobins Q-Ratio = 4.80 (Enterprise Value 265.7m / Total Assets 55.4m)
Interest Expense / Debt = 0.67% (Interest Expense 14.0k / Debt 2.09m)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -3.40m (EBIT -4.53m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 1.59 (Total Current Assets 43.6m / Total Current Liabilities 27.4m)
Debt / Equity = 0.08 (Debt 2.09m / totalStockholderEquity, last quarter 27.3m)
Debt / EBITDA = 3.12 (negative EBITDA) (Net Debt -5.39m / EBITDA -1.73m)
Debt / FCF = -0.74 (Net Debt -5.39m / FCF TTM 7.30m)
Total Stockholder Equity = 22.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 17.72% (Net Income 9.32m / Total Assets 55.4m)
RoE = 40.73% (Net Income TTM 9.32m / Total Stockholder Equity 22.9m)
RoCE = -19.71% (EBIT -4.53m / Capital Employed (Equity 22.9m + L.T.Debt 94.0k))
RoIC = -15.43% (negative operating profit) (NOPAT -3.40m / Invested Capital 22.0m)
WACC = 12.45% (E(271.1m)/V(273.2m) * Re(12.54%) + D(2.09m)/V(273.2m) * Rd(0.67%) * (1-Tc(0.25)))
Discount Rate = 12.54% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 20.0 | Cagr: 1.03%
[DCF] Terminal Value 53.47% ; FCFF base≈5.27m ; Y1≈3.46m ; Y5≈1.58m
[DCF] Fair Price = 1.11 (EV 17.9m - Net Debt -5.39m = Equity 23.3m / Shares 21.0m; r=12.45% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 61.67 | Revenue CAGR: 7.47% | SUE: -0.08 | # QB: 0
EPS current Year (2026-12-31): EPS=0.27 | Chg30d=+1.88% | Revisions=+20% | GrowthEPS=+8.1% | GrowthRev=+14.1%
EPS next Year (2027-12-31): EPS=0.34 | Chg30d=+3.01% | Revisions=+20% | GrowthEPS=+26.4% | GrowthRev=+13.5%
[Analyst] Revisions Ratio: +20%